 |
December 03, 2010
Dr Andras Fehervary offers the industry perspective on the barriers that are preventing patients joining clinical trials and explains how they are working to remove these barriers. The barriers ...
|
 |
November 25, 2010
Prof Tim Illidge speaks to ecancer.tv about the opening of the new patient treatment centre at The Christie NHS Foundation Trust in Manchester. This centre will allow The Christie Trust to further ...
|
 |
November 25, 2010
Helen Ferns speaks about the new patient treatment centre opening as part of the Christie NHS Foundation Trust in Manchester. This unit will be the largest early clinical trials unit in the world, ...
|
 |
November 24, 2010
Prof Alberto Sobrero speaks about some key clinical studies on colorectal cancer which were presented at ESMO 2010. Two of these trials looked at cediranib, an inhibitor of VEGF receptor tyrosine ...
|
 |
November 23, 2010
Prof Annamaria Colao speaks to ecancertv about Cushing’s disease; the causes of the disease, who is most susceptible and the difficulties of diagnosis. Cushing's disease is very severe ...
|
 |
November 23, 2010
Prof Annamaria Colao explains the causes and effects of acromegaly and discusses a number of trials comparing the efficacy of current therapies, investigating new first line treatments and ...
|
 |
November 23, 2010
Dr Alberto Pedroncelli speaks about two clinical trials, one to compare pasireotide with octreotide in medically naïve acromegaly patients and one to compare pasireotide with octreotide or ...
|
 |
November 17, 2010
www.ecancer.tv
|
 |
November 17, 2010
MEP Nessa Childers speaking at the Forum Against Cancer Europe (FACE) 'Cross Border Healthcare' meeting on the 15th September 2010. Organised by the European Cancer Patient ...
|
 |
November 10, 2010
Dr Nicola Fazio speaks about the different types of neuroendocrine tumours and the results of the Radiant-2 and Radiant 3 trials which were presented at ESMO 2010. Radiant 2 compared everolimus ...
|
 |
November 10, 2010
Prof Jonathan Ledermann talks about the possibility of using bevacizumab in the first line treatment of ovarian cancer. Research presented at ESMO 2010 in addition to previous research presented ...
|
 |
November 10, 2010
Prof Dorothy Keefe talks about three posters presented at the 2010 ESMO meeting in Milan. Two of these posters addressed pain management; one investigating the use of a nasal spray to administer ...
|
 |
November 10, 2010
Dr Johann de Bono speaks to ecancer.tv about PARP inhibitors, the benefits that these drugs have shown and what still needs to be done before they can be approved. Dr de Bono suggests how ...
|
 |
November 10, 2010
Prof Bernard Escudier of the Institut Gustave Roussy, Paris, talks to ecancer at ESMO 2010 about his work with reducing unnecessary treatment for renal cancer and improved targeting of treatment.
|
 |
November 10, 2010
Prof Francesco De Lorenzo speaks about an Italian multimedia service that aims to help recovering cancer patients return to work and regain a normal social life.This service provides information ...
|
 |
November 10, 2010
Dr Claudio Lombardo talks about the importance of effectively disseminating the goals, objectives and activities of OECI and how the new partnership with ecancer.tv will benefit information ...
|
 |
November 10, 2010
Dr James Mackay speaks about the increased requirement for genetic testing within oncology. There is currently an unacceptable level of variation in the turnaround times for these tests and this ...
|
 |
November 04, 2010
Prof Kjell Öberg discusses the development of new biomarkers which allow early detection of pNET and identify patients who are at high risk of recurrence after surgery and speaks about the ...
|
 |
November 04, 2010
Dr Chris Harrison explains how being part of OECI allows the Christie Centre to compare the service it offers with other institutes across Europe, to combine its resources and conduct research in ...
|
 |
November 04, 2010
Dr Mahasti Saghatchian talks about the OECI accreditation process which aims to provide a consistent set of good practice standards for patient care and research within the European cancer ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|